SIGN UP
LOG IN
Why Edgewise Therapeutics Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket
Benzinga·12/16/2024 11:37:55
Listen to the news
Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) rose sharply in today's pre-market trading after the company reported topline results from Phase 2 CANYON trial of Sevasemten in individuals with becker muscular dystrophy.
Edgewise Therapeutics shares jumped 26.5% to $35.00 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- Sidus Space, Inc. (NASDAQ:SIDU) gained 59.4% to $2.28 in pre-market trading after adding 9% on Friday.
- SEALSQ Corp (NASDAQ:LAES) gained 48.6% to $2.60 in pre-market trading after falling over 5% on Friday.
- U-BX Technology Ltd. (NASDAQ:UBXG) gained 32.3% to $4.40 in pre-market trading.
- PureTech Health plc (NASDAQ:PRTC) rose 22.8% to $25.00 in pre-market trading after the company reported positive results from ELEVATE IPF, a Phase 2b randomized, double-blind, active- and placebo-controlled, dose-ranging trial evaluating deupirfenidone (LYT-100) at two dose levels three times a day (TID) over 26 weeks in patients with idiopathic pulmonary fibrosis (IPF).
- BTC Digital Ltd. (NASDAQ:BTCT) gained 22.8% to $7.84 in pre-market trading.
- Sagimet Biosciences Inc. (NASDAQ:SGMT) climbed 17.2% to $5.15 in pre-market trading after falling over 3% on Friday.
- Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS) gained 14.4% to $30.72 in pre-market trading.
- Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) gained 13.8% to $0.2736 in pre-market trading after gaining 5% on Friday.
- BitFuFu Inc. (NASDAQ:FUFU) gained 9.1% to $5.64 in pre-market trading following a 9% decline on Friday.
Losers
- Akoustis Technologies, Inc. (NASDAQ:AKTS) shares tumbled 39.8% to $0.0410 in pre-market trading after the company filed for Chapter 11 and initiated strategic sale of business amid Qorvo legal dispute.
- Roadzen, Inc. (NASDAQ:RDZN) declined 32.6% to $1.20 in pre-market trading after the company priced its $2.5 million public offering of 2 million common shares at $1.25 per share.
- SMX (Security Matters) Public Limited Company (NASDAQ:SMX) shares fell 23.9% to $0.2160 in pre-market trading after the company announced the receipt of Nasdaq Listing Delinquency Notice.
- Karyopharm Therapeutics Inc (NASDAQ:KPTI) fell 21.6% to $0.55 in pre-market trading.
- AtlasClear Holdings, Inc. (NASDAQ:ATCH) dipped 20.5% to $0.1750 in pre-market trading.
- Innate Pharma S.A. (NASDAQ:IPHA) shares dipped 19.2% to $2.44 in pre-market trading after jumping 96% on Friday. The company, last week. announced its TELLOMAK Phase 2 trial of Lacutamab demonstrated significant symptom relief and quality of life improvements.
- 22nd Century Group, Inc. (NASDAQ:XXII) shares fell 17.5% to $0.0404 in pre-market trading after dipping 33% on Friday.
- Santech Holdings Limited (NASDAQ:STEC) fell 17.2% to $0.63 in pre-market trading.
- Super Micro Computer, Inc. (NASDAQ:SMCI) fell 12.5% to $31.85 in pre-market trading following reports suggesting the company tapped Evercore to raise capital and is considering raising equity and debt.
- SPI Energy Co., Ltd. (NASDAQ:SPI) fell 12.1% to $0.34 in today's pre-market trading after jumping over 10% on Friday.
Now Read This:
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.